Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
- Conditions
- Interventions
- First Posted Date
- 2010-11-04
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01234883
- Locations
- π¨π¦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada
πΊπΈEmory University/Children's Healthcare of Atlanta, Atlanta, Georgia, United States
π¨π¦Alberta Children's Hospital, Calgary, Alberta, Canada
Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
- Conditions
- Interventions
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 71
- Registration Number
- NCT01219959
- Locations
- π¨π΄
Rts Ltda Ag H.U.S, Bucaramanga, Colombia
π¨π΄RTS Ltda Versalles, Cali, Colombia
π¨π΄RTS Ltda Barranquila, Barranquila, Colombia
Gambro AK200 ULTRA Hemodiafiltration Study
- Conditions
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2017-07-13
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 14
- Registration Number
- NCT01202708
- Locations
- πΊπΈ
George Washington University Medical Center, Washington, D.C., District of Columbia, United States
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
- Conditions
- Interventions
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 5
- Registration Number
- NCT01181544
- Locations
- πΊπΈ
University of Louisville, Louisville, Kentucky, United States
Efficacy and Time and Resources for Hylenex-facilitated SC Rehydration Versus ORT for Dehydrated Children in the Emergency Department (ED)
- Conditions
- Interventions
- First Posted Date
- 2010-05-11
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT01120431
Study of In-line Pressure Using Various Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT1A)
- Conditions
- Interventions
- First Posted Date
- 2010-05-04
- Last Posted Date
- 2011-10-24
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT01116102
- Locations
- πΊπΈ
Kendle International, Inc. Drug Study Unit, Morgantown, West Virginia, United States
Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty
- First Posted Date
- 2010-04-28
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT01112735
- Locations
- πΊπΈ
UT Southwestern Medical Center, Department of Plastic Surgery, Dallas, Texas, United States
πΊπΈMei Li Surgery Center, Beverly Hills, California, United States
πΊπΈCenter for Plastic Surgery and Skin Care, Fort Lauderdale, Florida, United States
Open-label, Randomized Trial to Determine the Effect of Icodextrin Versus Dextrose (Dianeal 2.5%) in HOMA IR
- Conditions
- Interventions
- First Posted Date
- 2010-03-26
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Baxter Healthcare Corporation
- Registration Number
- NCT01093547
Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion
- Conditions
- Interventions
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT01018771
- Locations
- π¦πΊ
Moloney & Associates, Wollongong, Australia
Actifuse ABX Versus INFUSE in Posterolateral Instrumented Lumbar Fusion (PLIF) With Interbody Fusion
- Conditions
- Interventions
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2017-04-05
- Lead Sponsor
- Baxter Healthcare Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT01013389
- Locations
- π¦πΊ
Moloney & Associates, Wollongong, Australia
π³π±Isala Klinik, Zwolle, Netherlands